Redwood Pharma ABFNSE Redwood Pharma Stock Report

Redwood Pharma AB engages in the development, production, and marketing of opthalmic pharmaceuticals. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2016-06-15. The firm develops IntelliGel, a patented hydrogel drug delivery platform technology. IntelliGel is a patented supramolecular smart drug delivery system with an ability to dissolve water-insoluble and sparingly soluble drugs, or disperse, suspend and stabilize otherwise insoluble drugs. The company is an odor-free, clear and transparent hydrogel with low solid content, and forms an invisible patch when applied to a surface. The Company’s development product is focused on treatment of chronic Dry Eye Disease (DED) in post-menopausal women. The company is based on a naturally occurring, endogenous molecule found in the body.